BRIEF-Vaxxinity Receives FDA Fast Track Designation For Ub-311 For Treatment Of Alzheimer's Disease
BRIEF-Vaxxinity Receives FDA Fast Track Designation For Ub-311 For Treatment Of Alzheimer's Disease
Brief-Vaxxity獲得FDA指定用於治療阿爾茨海默病的Ub-311快速通道
May 2 (Reuters) - Vaxxinity Inc VAXX.O :
路透5月2日電-Vaxxity Inc VAXX.O：
* VAXXINITY RECEIVES FDA FAST TRACK DESIGNATION FOR UB-311 FOR TREATMENT OF ALZHEIMER'S DISEASE
*VAXXINITY獲得FDA指定的用於治療阿爾茨海默病的UB-311快速通道
* VAXXINITY RECEIVES FDA FAST TRACK DESIGNATION FOR UB-311 FOR TREATMENT OF ALZHEIMER'S DISEASE
*VAXXINITY獲得FDA指定的用於治療阿爾茨海默病的UB-311快速通道
Source text for Eikon: ID:nGNXDvWhm Further company coverage: VAXX.O
Eikon的源文本：ID：nGNXDvWhm進一步的公司報道：VAXX.O